ArticlePharmaceuticals (Basel, Switzerland)2025

Enhancing Tetrahydrocannabinol's Therapeutic Efficacy in Inflammatory Bowel Disease: The Roles of Cannabidiol and the Cannabinoid 1 Receptor Allosteric Modulator ZCZ011.

Dinesh Thapa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.